行情

DXR

DXR

DAXOR CORP
AMEX

实时行情|Nasdaq Last Sale

11.08
0.00
0.00%
已收盘, 16:00 09/21 EDT
开盘
11.04
昨收
11.08
最高
11.08
最低
11.04
成交量
950
成交额
--
52周最高
17.58
52周最低
8.58
市值
4,469.54万
市盈率(TTM)
140.61
分时
5日
1月
3月
1年
5年
Brief-Daxor Corp 提供的新数据验证了 BVA-100 血液检测对心力衰竭患者的益处
reuters.com · 09/14 12:52
Daxor 公司在重要科学学会会议上提供新数据,验证 BVA-100® 血液检测对心力衰竭患者的益处
Data from Three New Studies and Two Ongoing Trials Presented at the Heart Failure Society of America Annual Scientific Meeting 2021 Data Highlight Importance of Blood Volume Analysis in Providing Appropriate, Personalized Care to Patients with Heart Failur...
GlobeNewswire · 09/14 12:30
Daxor 公司将在 2021 年美国心力衰竭协会年度科学会议上展示使用 BVA-100 血液检测的新数据和临床试验
Daxor Corporation (NYSE:DXR), the global leader in blood volume measurement technology, , today announced it will exhibit at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2021
Benzinga · 09/08 12:50
Daxor 公司将在 2021 年美国心力衰竭协会年度科学会议上展示利用 BVA-100® 血液检测的引人注目的新数据和临床试验
Oak Ridge, TN, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, , today announced it will exhibit at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2021...
GlobeNewswire · 09/08 12:30
Daxor Corporation 将出席 HC Wainwright 第 23 届年度全球投资虚拟会议
Oak Ridge, TN, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE:DXR), the global leader in blood volume measurement technology, today announces that President and Chief Executive Officer Michael Feldschuh will present at the 23rd Annual H.C. Wain...
GlobeNewswire · 09/07 12:30
Daxor Corporation 首席执行官兼总裁 Michael Feldschuh 在致股东的信中提供公司最新情况
Daxor Corporation (NYSE:DXR), the global leader in blood volume measurement technology, announces today it issued a corporate update in a Letter to Shareholders filed in its certified shareholder report on form N-CSR on
Benzinga · 09/01 12:33
Daxor 报告截至 2021 年 6 月 30 日的 6 个月诊断销售收入增长 26.5%
Daxor Corporation (NYSE:DXR), the global leader in blood volume measurement technology, announces today it filed Form N-CSR disclosing its schedule of portfolio holdings for the six months ended June 30, 2021. The
Benzinga · 08/30 12:35
Daxor Corporation 报告称,截至 2021 年 6 月 30 日的六个月,N-CSR 申报表中的诊断销售收入增长了 26.5%
Company forecasts further increase in sales driven by new distributor agreements Oak Ridge, TN, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today it filed Form N-CSR d...
GlobeNewswire · 08/30 12:30
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解DXR最新的财务预测,通过DXR每股收益,每股净资产,每股现金流等数据分析DAXOR CORP近期的经营情况,然后做出明智的投资选择。
分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测DXR价格均价为22.00,最高价位22.00,最低价为22.00。
EPS
机构持股
总机构数: 4
机构持股: 7.98万
持股比例: 1.98%
总股本: 403.39万
类型机构数股数
增持
3
6,305
建仓
0
0
减持
1
2,000
平仓
3
7.46万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
先进医疗设备和技术
+0.38%
医疗设备和用品
+0.22%
高管信息
Chairman/President/Chief Executive Officer/Director
Michael Feldschuh
Chief Financial Officer
Robert Michel
Chief Scientific Officer/Director
Jonathan Feldschuh
Director
Henry Cremisi
Director
Edward Feuer
Independent Director
Joy Goudie
Independent Director
James Lombard
Independent Director
Robert Willens
公告日期
每股分红
除权日期
2017/12/28
每股分红:USD 0.03
2018/01/05
2016/11/18
每股分红:USD 0.03
2016/12/20
2015/12/09
每股分红:USD 0.04
2015/12/18
2014/11/17
每股分红:USD 0.03
2014/12/04
2013/11/15
每股分红:USD 0.05
2013/12/05
2012/11/29
每股分红:USD 0.1
2012/12/07
2012/08/03
每股分红:USD 0.1
2012/08/10
2011/11/08
每股分红:USD 0.1
2011/11/16
2011/05/25
每股分红:USD 0.15
2011/05/27
2010/11/30
每股分红:USD 0.65
2010/12/14
2010/09/02
每股分红:USD 0.25
2010/09/13
2010/05/11
每股分红:USD 0.1
2010/05/27
--
每股分红:USD 1
2009/12/08
--
每股分红:USD 0.25
2009/08/21
--
每股分红:USD 0.1
2009/05/27
--
每股分红:USD 1
2008/12/10
--
每股分红:USD 0.25
2008/10/31
--
每股分红:USD 0.25
2008/07/24
DXR 简况
Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The Company focuses on the development of the Blood Volume Analyzer (BVA) -100, an instrument that rapidly and accurately measures human blood volume. The Company’s instrument is used in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.The Company also owns the Daxor Oak Ridge Operations (DORO) facility in Oak Ridge, Tennessee. The semi-automated BVA provides blood volume measurements in human body for diagnosis and treatment in a range of medical and surgical conditions.

微牛提供Daxor Corporation(AMEX-DXR)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的DXR股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易DXR股票基本功能。